Foxhollow News (NASDAQ:FOXH)
| Latest Foxhollow Technologies News Headlines | | Date | Time | Source | | | 10/04/2007 | 5:14PM | PRNUS | ev3 and FoxHollow Technologies Announce Completion of Merger
PLYMOUTH, Minn. and REDWOOD CITY, Calif., Oct. 4 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV) and FoxHollow Technologies, Inc. (NASDAQ:FOXH) announced today the successful completion of their previously announced merger under which ev3 has now acquired all the outstanding shares of FoxHollow common stock, resulting... More...>> |
| 09/04/2007 | 10:25PM | PRNUS | ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
PLYMOUTH, Minn. and REDWOOD CITY, Calif., Sept. 4 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV) and FoxHollow Technologies, Inc. (NASDAQ:FOXH) announced today that FoxHollow has set October 4, 2007 as the date of the special meeting of FoxHollow stockholders to vote on the proposed merger with ev3. The record date... More...>> |
| 08/28/2007 | 8:30AM | PRNUS | FoxHollow Technologies Makes Significant Advancement in the Treatment of Below the Knee Arterial Disease With Introduction of Si
Equipped with proprietary MEC(TM) Technology, The SilverHawk(R) EXL increases tissue collection capacity and improves ease of use for physicians, representing considerable advancement in Below the Knee treatment of Peripheral Artery Disease
REDWOOD CITY, Calif., Aug. 28 /PRNewswire-FirstCall/ -- FoxHollow Technologies... More...>> |
| 08/08/2007 | 4:10PM | PRNUS | FoxHollow Technologies Reports Second Quarter 2007 Financial Results
Company Announces Conditional IDE Approval for the NightHawk Device, and Filing of RockHawk 510(k)
REDWOOD CITY, Calif., Aug. 8 /PRNewswire-FirstCall/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease (PAD), today announced... More...>> |
| 08/01/2007 | 5:29PM | PRNUS | FoxHollow Technologies Schedules Earnings Conference Call for August 8, 2007
REDWOOD CITY, Calif., Aug. 1 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH) announced that it will report its financial results for the second quarter 2007 after market close on Wednesday, August 8, 2007. The company will hold a conference call the same day at 2 p.m., Pacific Time (5 p.m. Eastern Time... More...>> |
| 06/15/2007 | 8:00AM | PRNUS | FoxHollow Technologies to Participate in William Blair 27th Annual Growth Stock Conference
REDWOOD CITY, Calif., June 15 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, is scheduled to participate in the William Blair 27th Annual Growth Stock Conference on Wednesday, June 20, 2007, in... More...>> |
| 06/08/2007 | 8:00AM | PRNUS | FoxHollow Technologies to Participate in the Goldman Sachs 28th Annual Global Healthcare Conference
REDWOOD CITY, Calif., June 8 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, is scheduled to participate in the Goldman Sachs 28th Annual Global Healthcare Conference on Tuesday, June 12, 2007, in... More...>> |
| 05/21/2007 | 8:30AM | PRNUS | FoxHollow Provides Update on Regulatory Process for Its NightHawk(TM) System
REDWOOD CITY, Calif., May 21 /PRNewswire-FirstCall/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), today announced that the company has plans to conduct a clinical study with its NightHawk Plaque Excision System under an Investigational Device Exemption application (IDE). In support of the IDE, FoxHollow has decided... More...>> |
| 05/17/2007 | 8:00AM | PRNUS | FoxHollow Technologies to Participate in Citigroup Global Healthcare Conference
REDWOOD CITY, Calif., May 17 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral and coronary artery disease, is scheduled to participate in the Citigroup Global Healthcare Conference on Thursday, May 24, 2007, in New... More...>> |
| 05/01/2007 | 4:15PM | PRNUS | FoxHollow Technologies Reports First Quarter 2007 Financial Results
REDWOOD CITY, Calif., May 1 /PRNewswire-FirstCall/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease (PAD), today reported results for the first quarter of fiscal 2007.
For the quarter ended March 31, 2007, the company... More...>> |
| 04/30/2007 | 8:30AM | PRNUS | FoxHollow Technologies to Participate in Morgan Stanley Global Healthcare Unplugged Conference
REDWOOD CITY, Calif., April 30 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral and coronary artery disease, is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May... More...>> |
| 04/18/2007 | 4:30PM | PRNUS | FoxHollow Technologies Schedules Earnings Conference Call for May 1, 2007
REDWOOD CITY, Calif., April 18 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH) announced that it will report its financial results for the first quarter 2007 after market close on Tuesday, May 1, 2007. The company will hold a conference call the same day at 2 p.m., Pacific Time (5 p.m. Eastern Time... More...>> |
| 04/03/2007 | 8:30AM | PRNUS | FoxHollow Technologies Introduces Enhanced Plaque Removal Technology for Treating Peripheral Artery Disease
The SilverHawk(R) SXL With Proprietary MEC(TM) Technology Increases Tissue Collection Capacity and Improves Ease of Use for Physicians
REDWOOD CITY, Calif., April 3 /PRNewswire-FirstCall/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), today announced the launch of the company's latest advancement in plaque excision... More...>> |
| 04/02/2007 | 8:30AM | PRNUS | FoxHollow Announces FDA 510(k) Submission for the NightHawk(TM) System
Submission represents significant milestone towards the commercialization of the Company's Proprietary Technology To Enable Real-Time Visualization Of Peripheral Vascular Morphology
REDWOOD CITY, Calif., April 2 /PRNewswire-FirstCall/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), today announced a 510(k) premarket... More...>> |
| 02/28/2007 | 9:00AM | PRNUS | FoxHollow Announces New Senior Vice President of Global Sales; Industry Veteran Brings Proven Experience in Leading Sales Initia
REDWOOD CITY, Calif., Feb. 28 /PRNewswire/ -- FoxHollow Technologies, Inc. (NASDAQ:FOXH), which develops and markets endovascular therapeutic devices for the treatment of peripheral artery disease (PAD), today announced the hiring of Kevin Cordell as the company's new Senior Vice President of Global Sales.
In his new... More...>> |
| 02/13/2007 | 4:15PM | PRNUS | FoxHollow Technologies Reports Fourth Quarter and Full-Year 2006 Financial Results
REDWOOD CITY, Calif., Feb. 13 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease (PAD), today reported results for the fourth quarter and full year 2006.
For the quarter ended December 31, 2006, the... More...>> |
| 02/06/2007 | 4:15PM | PRNUS | FoxHollow Technologies Schedules Earnings Conference Call for February 13, 2007
REDWOOD CITY, Calif., Feb. 6 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH) announced that it will report its financial results for the fourth quarter 2006 after market close on Tuesday, February 13, 2007. The company will hold a conference call the same day at 2 p.m., Pacific Time (5 p.m. Eastern Time... More...>> |
| 01/08/2007 | 8:30AM | PRNUS | ev3 Inc. and FoxHollow Technologies, Inc. Announce a Clinical Collaboration and Distribution Agreement for SpideRX(R) and RockHa
PLYMOUTH, Minn. and REDWOOD CITY Calif., Jan. 8 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV) and FoxHollow Technologies, Inc. (NASDAQ:FOXH) today announced they have entered into an agreement to conduct a joint clinical study of FoxHollow's calcium cutting device (The RockHawk) and ev3's SpideRX endovascular devices... More...>> |
| 01/08/2007 | 8:30AM | PRNUS | ev3 Inc. and FoxHollow Technologies, Inc. Announce a Clinical Collaboration and Distribution Agreement for SpideRX(R) and RockHa
PLYMOUTH, Minn. and REDWOOD CITY, Calif., Jan. 8 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV) and FoxHollow Technologies, Inc. (NASDAQ:FOXH) today announced they have entered into an agreement to conduct a joint clinical study of FoxHollow's calcium cutting device (The RockHawk) and ev3's SpideRX endovascular devices... More...>> |
| 01/08/2007 | 8:25AM | PRNUS | FoxHollow Technologies Provides Update on Corporate Strategy; Announces Preliminary Fourth Quarter 2006 Revenue of $44.7 Million
REDWOOD CITY, Calif., Jan. 8 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, today provided an update on the company's strategic direction. John Simpson, Ph.D., M.D., chief executive officer, will... More...>> |
|
|
|